No big sales with their rhinoswab. If that ever takes off the share price will follow. The Australian market is flooded with RATS with standard swabs and will take a long time to burn them up. The rest of the world would have the same issue. The next quarterly will be a cut and paste from the previous announcement.
Does the health sector think it's a gimmick product,?
